Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × Gefitinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 EGFR-mutant Non-small Cell Lung Cancer 1

Interventions

entrectinib 2 Magnetic Resonance Spectroscopy 2 tremelimumab 1 trametinib 1 selpercatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 dabrafenib 1 cobimetinib 1 X-Rays 1 Vemurafenib 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Specimen Handling 1 Mitoxantrone 1 Iodine-131 1 High-Energy Shock Waves 1 Glycoprotein Hormones, alpha Subunit 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡